fashion -WSS

fashion

author：fashion 2025-10-06 06:42:42 - browse：9497

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

LONDON — Starting in the new year, a team of researchers in the U.K. and Denmark will begin recruiting patients for a study driven by a pressing question in medicine: How should new obesity medications be incorporated into regular practice?

Trials have demonstrated that the powerful drugs can help people shed weight in dramatic ways, but clinicians are still trying to sort out how to best use them. The medicines, after all, are pricey, come with side effects, and won’t work for everyone. And despite the excitement around these drugs, known as GLP-1s, some people might prefer or see better results with the other approaches that have long been the foundation of obesity treatment, from diet to surgery.

“These drugs clearly are very effective, and that is fantastic,” said Susan Jebb, a professor of diet and population health at the University of Oxford and one of the leaders of the project. “But we have other options for treating obesity. What we need to do now in research is understand which treatments, for which patients, at which stage of their disease.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Hospitals look to new technology to keep health care workers safe

WSS

Poor hospice wound care hurts patients and families

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

UpToDate has a racism problem: Dr. Stanley Goldfarb

hotspot

fashion

focus

Anesthesiologist group: stop taking Ozempic before surgery

Security flaws in third

BioMarin wins approval for gene therapy to treat hemophilia A

Hospitals look to new technology to keep health care workers safe

Trump demands the U.S. pay no more for drugs than other countries … again

Undocumented workers face uncertainty as immigration law takes effect in Florida

As demand for Covid shots wanes, Moderna seeks its next success

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Hepatitis C has a cure — but many Americans still lack access to it

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Wikipedia

CRISPR pioneers react to Casgevy, first gene

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Readout LOUD podcast: A CRISPR milestone, biotech mixology

What affirmative action's end means to a medical student

Anthos stroke drug appears safer than common blood thinner

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

leisure time

hotspot

explore

entertainment